FI770160A - - Google Patents

Info

Publication number
FI770160A
FI770160A FI770160A FI770160A FI770160A FI 770160 A FI770160 A FI 770160A FI 770160 A FI770160 A FI 770160A FI 770160 A FI770160 A FI 770160A FI 770160 A FI770160 A FI 770160A
Authority
FI
Finland
Application number
FI770160A
Other languages
Finnish (fi)
Inventor
Klaus Hasspacher
Michael Strasser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI770160A publication Critical patent/FI770160A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI770160A 1976-01-28 1977-01-19 FI770160A (US06589383-20030708-C00041.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH107076 1976-01-28
CH107176 1976-01-28

Publications (1)

Publication Number Publication Date
FI770160A true FI770160A (US06589383-20030708-C00041.png) 1977-07-29

Family

ID=25686556

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770160A FI770160A (US06589383-20030708-C00041.png) 1976-01-28 1977-01-19

Country Status (12)

Country Link
US (1) US4094987A (US06589383-20030708-C00041.png)
JP (1) JPS5293766A (US06589383-20030708-C00041.png)
AU (1) AU2168677A (US06589383-20030708-C00041.png)
DE (1) DE2701705A1 (US06589383-20030708-C00041.png)
DK (1) DK20777A (US06589383-20030708-C00041.png)
ES (1) ES455346A1 (US06589383-20030708-C00041.png)
FI (1) FI770160A (US06589383-20030708-C00041.png)
FR (1) FR2339598A1 (US06589383-20030708-C00041.png)
IL (1) IL51334A0 (US06589383-20030708-C00041.png)
NL (1) NL7700681A (US06589383-20030708-C00041.png)
PT (1) PT66120A (US06589383-20030708-C00041.png)
SE (1) SE7700606L (US06589383-20030708-C00041.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78625A1 (de) * 1977-12-02 1979-06-13 Byk Gulden Lomberg Chem Fab Substituierte 1-phenyl-2-pyrrolidin-2-yl-ethanole,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel
CA1147339A (en) * 1979-12-05 1983-05-31 Folke L. Arvidsson Phenyl-azacykloalkanes
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CN101754962B (zh) 2007-07-19 2013-12-25 赛马拜制药公司 作为rup3或gpr119受体的激动剂治疗糖尿病和代谢性病症的n-氮杂环状经取代吡咯、吡唑、咪唑、三唑和四唑衍生物
CN102203074A (zh) * 2008-06-20 2011-09-28 麦它波莱克斯股份有限公司 芳基gpr119激动剂及其用途
US8410127B2 (en) 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
EP2585048B1 (en) 2010-06-23 2018-04-11 CymaBay Therapeutics, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283452A (en) * 1970-07-24 1972-07-26 Parke Davis & Co Substituted 1,3-dialkylpyrrolidines and processes for their production

Also Published As

Publication number Publication date
PT66120A (fr) 1977-02-01
IL51334A0 (en) 1977-03-31
AU2168677A (en) 1978-08-03
NL7700681A (nl) 1977-08-01
ES455346A1 (es) 1978-12-01
SE7700606L (sv) 1977-07-29
JPS5293766A (en) 1977-08-06
DK20777A (da) 1977-07-29
FR2339598A1 (fr) 1977-08-26
DE2701705A1 (de) 1977-08-04
US4094987A (en) 1978-06-13

Similar Documents

Publication Publication Date Title
DE2639718C2 (US06589383-20030708-C00041.png)
DE2640540C3 (US06589383-20030708-C00041.png)
FI770160A (US06589383-20030708-C00041.png)
DE2610845C3 (US06589383-20030708-C00041.png)
DE2647716C2 (US06589383-20030708-C00041.png)
DE2624853B2 (US06589383-20030708-C00041.png)
JPS52101193U (US06589383-20030708-C00041.png)
JPS555796Y2 (US06589383-20030708-C00041.png)
DE2639425C2 (US06589383-20030708-C00041.png)
DE2652863C2 (US06589383-20030708-C00041.png)
JPS5347419U (US06589383-20030708-C00041.png)
JPS571401Y2 (US06589383-20030708-C00041.png)
DE2616174C2 (US06589383-20030708-C00041.png)
JPS5613444Y2 (US06589383-20030708-C00041.png)
JPS5348509U (US06589383-20030708-C00041.png)
JPS5372096U (US06589383-20030708-C00041.png)
JPS5343278U (US06589383-20030708-C00041.png)
JPS5298603U (US06589383-20030708-C00041.png)
CS178388B1 (US06589383-20030708-C00041.png)
BE851885A (US06589383-20030708-C00041.png)
DD127213A1 (US06589383-20030708-C00041.png)
CH598497A5 (US06589383-20030708-C00041.png)
BG23446A1 (US06589383-20030708-C00041.png)
CH601737A5 (US06589383-20030708-C00041.png)
BG23427A1 (US06589383-20030708-C00041.png)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG